The global single-use bioprocessing market will register a 16.1% CAGR in terms of revenue and is expected to reach US$ 84.12 billion by 2030 from USD 21.98 billion in 2021.
Single-use bioprocessing systems are known for developing pharmaceuticals such as medicines, vaccines, and monoclonal antibodies by using disposable or single-use technologies. The use of single-use bioprocessing technologies during the development phase of drugs has witnessed exponential growth in the past few years. The single-use bioprocessing technologies are being used increasingly by the contract manufacturers in biopharmaceutical industry for acquiring the benefits such as low investment, low environmental footprint, and reliability. This is one of the primary factors propelling the growth of the global single-use bioprocessing market.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.novaoneadvisor.com/report/sample/6115
The growing geriatric population is boosting the market growth significantly. The growing prevalence of chronic conditions and diseases amongst the old age population is boosting the demand for the biopharmaceutical medicines. According to the United Nations, the old age population of 65 years or above will reach up to 1.5 billion by 2050. This is estimated to foster the single-use bioprocessing market in the future. Moreover, increasing investments in the development of numerous vaccines, drugs, and diagnostic tests is positively impacting the market growth.
The single-use bioprocessing market is significantly driven by the growing demand from the biopharmaceutical industry. Majority of the biopharmaceutical companies are increasingly adopting the single-use bioprocessing technology because the single-use bioprocessing systems increases the efficiency in the process and reduces the costs associated with sterilization, cleaning, and maintenance of steel bioreactors. In biopharmaceutical, the single-use bioprocessing system is used in a wide range of applications such as storage, filtration, purification, and mixing. Moreover, the biopharmaceuticals is rapidly growing. The biopharmaceutical alone forms around 20% of the global pharma market. The extensive use of biopharmaceuticals as therapeutic agents like cell therapies, allergenic agents, and vaccines to name a few. It is also used in the treatment of cancer. Hence, the rapid growth of biopharmaceuticals is significantly boosting the demand for the single-use bioprocessing system.
- By product, the media bags and containers segment led the global single-use bioprocessing market with remarkable revenue share in 2020. This is due to the benefits associated with the media bags and containers such as low capital requirement, saving of cost in sterilization and cleaning, operating scale flexibility, quick batch changeover and quick deployment, and cleaning validation elimination.
- By application, the filtration segment led the global single-use bioprocessing market with remarkable revenue share in 2020. This is attributed to the increasing adoption of single-use bioprocessing system infiltration owing to its flexibility. It is applicable in a wide variety of biopharmaceutical applications depending on the type of solutions used and is very much effective in eliminating viruses and other such cultures.
- By End User, the biopharmaceutical manufacturer segment led the market in 2020 as rapid growth of biopharmaceuticals industry. The biopharmaceutical industry alone represents over 20% of the total pharmaceutical industry and is rapidly growing across the markets like North America and Europe.
North America is the leading single-use bioprocessing market owing to the increased spending on healthcare, technological development in bioprocessing, and the growing importance of life science research. Growing adoption of disposable systems and increased energy efficiency coupled with the minimal risk of product cross-contamination are the beneficial factors associated with the use of single-use bioprocessing products. Further, the introduction of automation, big data technology, and artificial intelligence in the single-use system has been gaining rapid traction in North America. These latest technologies in the manufacturing units are expected to boost production and help the manufacturers to achieve cost-efficiency and reduce wastages. The presence of a large number of big and small contract manufacturing organizations in the region are increasingly using the single-use bioprocessing technology due to its low cost and improved output. The increased economic activity of these contract manufacturers will significantly drive the growth of the single-use bioprocessing market in North America.
The Asia Pacific is characterized by the growing production of biosimilars, cell therapy, vaccines, and various other types of biopharmaceutical products. Moreover, China is the second-largest biopharmaceutical market just after the US. China’s economic policies to attract FDIs for setting up manufacturing plants for biopharmaceutical products is exponentially fostering the demand for single-use bioprocessing technology. Moreover, nations like India, Japan, and South Korea have been leading players in the Asia Pacific region. Biocon of India and Samsung Biologics of South Korea have earned FDA and European Medicines Agency approval respectively, for their new biosimilar products in 2017. Therefore, the single-use bioprocessing market has huge growth potential in the Asia Pacific region.
Drivers – The single-use bioprocessing market is significantly driven by the growing demand from the biopharmaceutical industry. Majority of the biopharmaceutical companies are increasingly adopting the single-use bioprocessing technology because the single-use bioprocessing systems increases the efficiency in the process and reduces the costs associated with sterilization, cleaning, and maintenance of steel bioreactors. This drives the higher adoption of disposable bioprocessing systems in the biopharmaceutical industry.
Restraints – The Bio-Process System Alliance has published a set of tests to be performed regarding the extractable and leachable contamination. The leachable and extractable are the unwanted products produced by the single-use bioprocessing system. The disposable bioprocessing system are made of plastic and often faces contamination issues. This may hamper the single-use bioprocessing market growth.
Opportunities – The emerging markets such as China and India have a high growth potential. The growing investments by the major players, growing geriatric population, and rapidly growing biotechnology in the industry is providing lucrative growth opportunities to the single-use bioprocessing market players.
Challenges – The plastic wastes generated by the disposable bioprocessing system is a major challenge faced by the market players due to the growing environmental concerns and government regulation regarding plastic wastes.
In the final section of the research report, Nova One Advisor provided the global single-use bioprocessing market structure and a detailed competition landscape to provide a dashboard view of key players operating in the single-use bioprocessing market along with their business strategies to report audiences. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the value chain of the market.
Some of the major players in the single-use bioprocessing market include:
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- Merck KGaA
- Pall Corporation
- Corning Incorporated
- Eppendorf AG
- General Electric Company (GE Healthcare)
- Rentschler Biopharma SE
- JM BioConnect
- Meissner Filtration Products, Inc.
- Infors AG
- BoehringerIngelheim GmbH
- Entegris, Inc.
- PBS Biotech, Inc.
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:
Segments Covered in the Report
- Filtration Assemblies
- Disposable Bioreactors
- Disposable Mixers
- Media Bags & Containers
- Cell Culture
By End User
- Biopharmaceutical Manufacturers
- Clinical & Academic Research Institutes
- United Kingdom
- Rest of Europe
- Southeast Asia
- Rest of Asia Pacific
- Rest of Latin America
Middle East & Africa (MEA)
- North Africa
- South Africa
- Rest of Middle East & Africa
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 3500) @ https://www.novaoneadvisor.com/report/checkout/6115
Call: +1 9197 992 333